{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:42:08Z","timestamp":1793889728517,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["1908085MH271"],"award-info":[{"award-number":["1908085MH271"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701606"],"award-info":[{"award-number":["81701606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.intimp.2020.107231","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T13:43:18Z","timestamp":1607434998000},"page":"107231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Association of IL-35 expression and gene polymorphisms in rheumatoid arthritis"],"prefix":"10.1016","volume":"90","author":[{"given":"Qiang","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Yu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Chong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.intimp.2020.107231_b0005","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and Management of Rheumatoid Arthritis: A Review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.intimp.2020.107231_b0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","article-title":"Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis","volume":"15","author":"Chen","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.intimp.2020.107231_b0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.autrev.2018.01.017","article-title":"Emerging role of IL-35 in inflammatory autoimmune diseases","volume":"17","author":"Su","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2020.107231_b0020","article-title":"Interleukin-35 promotes Th9 cell differentiation in IgG4-related disorders: experimental data and review of the literature","author":"Zhang","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107231_b0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cyto.2014.05.015","article-title":"Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice","volume":"69","author":"Thiolat","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2020.107231_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189617","article-title":"Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg\/Th17 ratio","volume":"12","author":"Zongyi","year":"2017","journal-title":"PLoS ONE"},{"issue":"2010","key":"10.1016\/j.intimp.2020.107231_b0035","first-page":"2569","article-title":"rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2020.107231_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2018.09.028","article-title":"Plasma interleukin-38 in patients with rheumatoid arthritis","volume":"65","author":"Xu","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.107231_b0045","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.107231_b0050","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.107231_b0055","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.107231_b0060","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2020.107231_b0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis","volume":"27","author":"Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.107231_b0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamaophthalmol.2017.0245","article-title":"Association of a haplotype in the NR3C2 gene, encoding the mineralocorticoid receptor, with chronic central serous chorioretinopathy","volume":"135","author":"van Dijk","year":"2017","journal-title":"JAMA. Ophthalmol"},{"key":"10.1016\/j.intimp.2020.107231_b0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12026-018-8998-3","article-title":"IL-35: a new immunomodulator in autoimmune rheumatic diseases","volume":"66","author":"Sakkas","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2020.107231_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49748-z","article-title":"The Plasma Interleukin (IL)-35 Level and Frequency of Circulating IL-35+ Regulatory B Cells are Decreased in a Cohort of Chinese Patients with New-onset Systemic Lupus Erythematosus","volume":"9","author":"Ye","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2020.107231_b0085","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/0961203315585815","article-title":"Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus","volume":"24","author":"Cai","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2020.107231_b0090","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12718","article-title":"Aberrant IL-35 levels in patients with primary Sjogren's syndrome","volume":"88","author":"Guo","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2020.107231_b0095","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1089\/jir.2018.0059","article-title":"Elevation of Serum IL-35 in Patients with Primary Sj\u00f6gren's Syndrome","volume":"38","author":"Han","year":"2018","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.intimp.2020.107231_b0100","first-page":"5366","article-title":"Decreased regulatory T-cell frequency and interleukin-35 levels in patients with rheumatoid arthritis","volume":"16","author":"Zhang","year":"2018","journal-title":"Exp. Ther Med."},{"key":"10.1016\/j.intimp.2020.107231_b0105","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/keu528","article-title":"Immunoregulatory role of IL-35 in T cells of patients with rheumatoid arthritis","volume":"54","author":"Nakano","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2020.107231_b0110","doi-asserted-by":"crossref","first-page":"e0132674","DOI":"10.1371\/journal.pone.0132674","article-title":"Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis","volume":"10","author":"\u0160enolt","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.107231_b0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cyto.2015.01.019","article-title":"Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis","volume":"73","author":"Filkov\u00e1","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2020.107231_b0120","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9139145","article-title":"Correlation between Serum IL-35 Levels and Bone Loss in Postmenopausal Women with Rheumatoid Arthritis","volume":"2019","author":"Li","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/j.intimp.2020.107231_b0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jim-2018-000814","article-title":"Elevated serum IL-35 levels in rheumatoid arthritis are associated with disease activity","volume":"67","author":"Li","year":"2019","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.intimp.2020.107231_b0130","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3389\/fimmu.2018.02691","article-title":"Delivery of IL-35 by Lactococcuslactis Ameliorates Collagen-Induced Arthritis in Mice","volume":"9","author":"Maddaloni","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2020.107231_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.intimp.2016.02.018","article-title":"Interleukin-35 attenuates collagen-induced arthritis through suppression of vascular endothelial growth factor and its receptors","volume":"34","author":"Wu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.107231_b0140","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/febs.14801","article-title":"IL-35 ameliorates collagen-induced arthritis by promoting TNF-\u03b1-induced apoptosis of synovial fibroblasts and stimulating M2 macrophages polarization","volume":"286","author":"Peng","year":"2019","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.intimp.2020.107231_b0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MCA.0000000000000635","article-title":"Association between interleukin-35 polymorphisms and coronary heart disease in the Chinese Zhuang population: a case\u2013control study","volume":"29","author":"Lin","year":"2018","journal-title":"Coron. Artery. Dis."},{"key":"10.1016\/j.intimp.2020.107231_b0150","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6012795","article-title":"Interleukin 35 polymorphisms are associated with decreased risk of premature coronary artery disease, metabolic parameters, and IL-35 levels: the genetics of atherosclerotic disease (GEA) study","volume":"2017","author":"Posadas-S\u00e1nchez","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2020.107231_b0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cyto.2015.09.007","article-title":"Association between polymorphisms of interleukin 12 and rheumatoid arthritis associated biomarkers in a Chinese population","volume":"76","author":"Shen","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.intimp.2020.107231_b0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/cei.12563","article-title":"Association of polymorphisms in interleukin (IL)-12A and -B genes with rheumatoid arthritis in a Chinese population : Association of IL-12A and IL-12B with RA","volume":"180","author":"Wang","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2020.107231_b0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/biom9040157","article-title":"Association between Interleukin 35 Gene Single Nucleotide Polymorphisms and Systemic Lupus Erythematosus in a Chinese Han Population","volume":"9","author":"Guan","year":"2019","journal-title":"Biomolecules."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:42:52Z","timestamp":1762551772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920336985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":33,"alternative-id":["S1567576920336985"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107231","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of IL-35 expression and gene polymorphisms in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107231"}}